Do you want to use your skills and expertise to help change the world by playing a part in the development of new and innovative therapies?
Who are we?
We Are PRA.
We are 15,000+ employees strong, operating in more than 85 countries. We are committed to saving lives and we are constantly striving to be the best at what we do. Our impact is real and we see it every single day. We help get life-saving drugs into the hands of those who need them most.
Who are you?
You are flexible, efficient, proactive, and highly movitated. You are able to create and re-set priorities in a fast-paced environment without sacrificing your attention to detail. You work well within a team, both in a leadership role and as a contributor. You are a confident negotiator, love a challenge, and can independently create solutions to complex issues. The idea of improving the lives of others by using your analytical and interpersonal skills excites you. Despite a demanding day or difficult discussion, you are able to walk away with your sense of humor intact.
In your next career move, you want to work for a company that supports your professional growth and helps you find a work/life balance. You want to expand your knowledge, develop your skill set, and build your career. Most of all, you want to do it in a place where you’re part of a team as zealous about their work as you are -- a place where you can really make a difference.
What will you be doing?
You will be a key member of the Study Start-Up team. You will be responsible for reviewing and negotiating contract language and budgets for sites involved in clinical trials. You will manage and oversee the timely delivery of contracts for individual projects or across a client portfolio. You will identify and escalate issues before they become critical and adjust quickly to the changes of a dynamic organization. Additionally, you will:
What do you need to have?
PRA is an EEO/AA employer and is committed to providing opportunities to minorities, women, veterans, and individuals with disabilities.